(Q36669430)

15 August 2017

1 reference

title

The MCID of the transition dyspnea index is a total score of one unit (English)

1 reference

15 August 2017

Donald A Mahler

1

1 reference

15 August 2017

Theodore J Witek

series ordinal

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

15 August 2017

published in

1 reference

15 August 2017

volume

2

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

99-103

1 reference

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

A measure of quality of life for clinical trials in chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Use of factor analysis to consolidate multiple outcome measures in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Effects of theophylline withdrawal in severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Salmeterol plus theophylline combination therapy in the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Formoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Randomised controlled trial of respiratory rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

General exercise training improves ventilatory and peripheral muscle strength and endurance in chronic airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Results of a home-based training program for patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Respiratory muscle endurance training in chronic obstructive pulmonary disease: impact on exercise capacity, dyspnea, and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Inspiratory muscle training in patients with COPD: effect on dyspnea, exercise performance, and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Maintenance of inspiratory muscle training in COPD patients: one year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Meaningful effect size and patterns of response of the transition dyspnea index

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Minimal important difference of the transition dyspnoea index in a multinational clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

Methods to explain the clinical significance of health status measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCOPD-200050666

21 January 2018

Identifiers

DOI

10.1081/COPD-200050666

1 reference

15 August 2017

1 reference